We annotated stroma- and cancer cell-associated CD8+ T cells using QuPath (Figure 6A) in a cohort of 40 patients represented by TMA cores from matched primary, metastatic, and recurrent tumors (two of the 42 patients were excluded from the analysis due to an insufficient quantity of fibroblasts or epithelial cancer cells in the cores). The gene discussed is CD8A; the disease is cancer.